Market Watch Highlights: Tenaya Therapeutics Inc (TNYA) Ends on an Downturn Note at 1.05

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

As of close of business last night, Tenaya Therapeutics Inc’s stock clocked out at $1.05, down -0.94% from its previous closing price of $1.06. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 1.54 million shares were traded. TNYA stock price reached its highest trading level at $1.09 during the session, while it also had its lowest trading level at $1.02.

Ratios:

To gain a deeper understanding of TNYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.

On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.

On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 18 ’24 when Saito Chihiro sold 2,258 shares for $2.12 per share. The transaction valued at 4,787 led to the insider holds 60,983 shares of the business.

Saito Chihiro sold 2,363 shares of TNYA for $6,840 on Aug 16 ’24. The SVP, Accounting and Fin. Ops. now owns 63,241 shares after completing the transaction at $2.89 per share. On Aug 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 7,428 shares for $2.89 each. As a result, the insider received 21,500 and left with 107,106 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 83181520 and an Enterprise Value of 18250542.

Stock Price History:

The Beta on a monthly basis for TNYA is 2.85, which has changed by -0.7680525 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -48.24%, while the 200-Day Moving Average is calculated to be -62.26%.

Shares Statistics:

It appears that TNYA traded 5.24M shares on average per day over the past three months and 1755860 shares per day over the past ten days. A total of 79.22M shares are outstanding, with a floating share count of 65.57M. Insiders hold about 17.24% of the company’s shares, while institutions hold 57.48% stake in the company. Shares short for TNYA as of 1736899200 were 11479520 with a Short Ratio of 2.19, compared to 1734048000 on 16690310. Therefore, it implies a Short% of Shares Outstanding of 11479520 and a Short% of Float of 20.75.

Most Popular